Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions

Journal of Endocrinological Investigation

Volumn 27, Issue 2, 2004, Pages

  Santini, Ferruccio ^a   Marsili, A ^a   Mammoli, C ^a   Valeriano, R ^a   Scartabelli, G ^a   Pelosini, C ^a   Giannetti, M ^a   Centoni, R ^a   Vitti, P ^a   Pinchera, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adiponectin; Hyperthyroidism; Hypothyroidism; Leptin; Obesity

Indexed keywords

ADIPONECTIN; LEPTIN; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; METABOLIC REGULATION; NODULAR GOITER; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 11144355544     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03346252     Document Type: Article

References (32)

1. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 2002, 25: 855-61.
2. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13: 84-9.
3. Tsao TS, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002, 440: 213-21.
4. Prins JB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2000, 16: 639-51.
5. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83.
6. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86: 3815-9.
7. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277: 37487-91.
8. Biondi B, Palmieri EA, Lombardi G, Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002, 12: 505-10.
9. Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003, 88: 2714-8.
10. 3-LI adipocytes. Biochem Biophys Res Commun 2002, 290: 1084-9.
11. Dimitriadis GD, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 2001, 109: 225-39.
12. Duntas LH. Thyroid disease and lipids. Thyroid 2002, 12: 287-93.
13. Ineck BA, Ng TM. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother 2003, 37: 725-30.
14. Pucci E, Chiovato, L, Pinchera A. Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 2000, 24: 109-12.
15. Hsueh WA, Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am J Cardiol 2003, 92: 3-9.
16. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 2002, 967: 363-78.
17. Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 2002, 80: 696-702.
18. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360: 57-8.
19. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941-6.
20. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 277: 25863-6.
21. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423: 762-9.
22. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002, 103: 137-42.
23. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-5.
24. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285: 527-33.
25. Zhang Y, Matheny M, Zolotukhin S, Tumer N, Scarpace PJ. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 2002, 1584: 115-22.
26. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y, Brichard SM. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J 2002, 367: 677-85.
27. Iglesias P, Alvarez Fidalgo P, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003, 59: 621-9.
28. Korbonits M. Leptin and the thyroid-a puzzle with missing pieces. Clin Endocrinol (Oxf) 1998, 49: 569-72.
29. Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997, 7: 407-9.
30. Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol 1997, 137: 659-63.
31. Matsubara M, Yoshizawa T, Morioka T, Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. J Atheroscler Thromb 2000, 7: 50-4.
32. Kautzky-Willer A, Ludwig C, Nowotny P, et al. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment. Eur J Clin Invest 1999, 29: 395-403.